Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Mindfulness-Based Intervention for Adolescents (Mindfulteen)

14 janvier 2021 mis à jour par: Camille Nemitz Piguet, University of Geneva, Switzerland

Early Mindfulness-based Intrevention for Anxious Adolescents: a fMRI Randomized Controlled Trial

The Mindfulteen Study is a 3-year long longitudinal cohort study with a nested randomized controlled trial, integrating neuroimaging, biological and clinical outcomes, and designed to evaluate the impact of a mindfulness-based intervention (MBI) on young adolescents.

Young adolescents between 13 and 15 years with no history of current mental health disorder (with the exception for anxiety symptoms) or of psychotherapy are included and randomized to either early or late intervention (i.e. waiting list or control group), after being stratified between low or high anxiety group based on State and Trait Anxiety Inventory (STAI-T) score. Participants on the control group participate on MBI after completing the second assessment. The intervention is an 8-week long MBI adapted to adolescents. Primary outcomes are based on neuroimaging (structural and functional MRI) and secondary outcomes are clinical (self-reported questionnaires covering mostly emotion and stress reactivity and trait mindfulness) and biological (cortisol, inflammation markers and redox markers). Assessments are performed at baseline, immediately after intervention or waiting time and after 18 months of intervention.

Aperçu de l'étude

Description détaillée

Promotion of mental health is a major concern worldwide, particularly among young population as major psychiatric diseases can have their onset during adolescence and young adulthood. During adolescence, there is growing evidence that "at-risk" states for mental disorders, as high stress reactivity for example, can be identified prior to clinical symptoms, and that early interventions can have a major impact preventing the further development of full-blown mental illness.

In the last two decades, given a growing interest for non-pharmacological approaches to improve mental and physical health, mindfulness-based interventions (MBI) have received serious attention. After the initial applications on chronic pain, stress reduction and prevention of depressive relapses, MBIs are now widely implemented among clinical and non-clinical populations.

Therefore, investigators aim to better understand the modifications of brain circuits involved in the emergence of stress related disorders and the impact of a MBI on those circuits. Hence, a translational project was designed, integrating neuroimaging, biological and clinical outcomes of stress reactivity to evaluate the impact of a MBI on adolescents.

The Mindfulteen Study is a 3-year longitudinal cohort study with a nested randomized controlled trial. The randomized controlled trial part of the study was designed to assess the clinical effect of MBI on adolescents, comparing to a control group. Therefore, after inclusion participants are electronically randomized between either early intervention group or late intervention group (i.e., waiting list or control group). Participants allocated in the late intervention group engage in MBI after the waiting period, providing data also for the longitudinal cohort part of the study and therefore increasing the data available for before and after comparison. The long-term effect of MBI will be assessed after 18 months of intervention.

Before randomization, participants are stratified according to their score on the trait questionnaire of the State Trait Anxiety Inventory (STAI) as low anxiety group (≤ 31) or high anxiety group (>31).

Assessments are performed before intervention, immediately after intervention or waiting period and in 18 months. For the late intervention group, an additional assessment is performed immediately after the intervention.

The overall objective of the Mindfulteen Study is to assess the immediate and long-term effect of an MBI on reactivity to stress and anxiety, in a non-clinical sample of young adolescents from the general population. Underlying psychological and biological changes are assessed using a multimodal brain MRI protocol, blood and hair sampling, as well as physiological measurements of stress.

The primary aim is to characterize brain functional modifications in cortico-limbic and cortico-striatal-thalamic circuits (functional MRI data) and their underlying neuroanatomical changes (analysis of structural, spectroscopy and diffusion MRI data) in adolescents exposed to MBI, comparing adolescents with high anxiety and low anxiety levels.

Secondary aims include the effects of MBI on self-reported levels of anxiety, emotion regulation strategies (clinical scores) and physiological markers of hypothalamic-pituitary-adrenal axis (hair cortisol), as well as biological markers of oxidative stress and inflammation (blood sampling).

Type d'étude

Interventionnel

Inscription (Anticipé)

120

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Geneva, Suisse, 1205
        • Recrutement
        • Geneva University
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

13 ans à 15 ans (Enfant)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Age 13 to 15 year-old
  • Interest in participating in a mindfulness based intervention
  • Francophone
  • Have access to internet and a to a compatible device (smartphone or tablet) every day to run the study's application
  • Availability for the study duration
  • Consent documented by signature and support from the legal representatives as documented by a signature
  • Informed Consent as documented by a signature

Exclusion Criteria:

  • History of chronic somatic disease or clinically significant medical condition (e.g., asthma, diabetes, renal failure, hepatic dysfunction, etc.)
  • History of neurologic or major psychiatric disease (except for an anxious disorder without comorbidity and a history of major depressive episode resolved for at least 6 months).
  • History of psychotherapy in the past 6 months
  • History of regular meditation practice
  • Women who are pregnant or breast feeding
  • Known or suspected non-compliance, drug or alcohol abuse,
  • Inability to participate in group sessions,
  • Previous enrolment into the current study
  • Inability to undergo study's procedures (IRM and blood sample collection)

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation croisée
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Early Mindfulness Intervention
The Early MBI group partake on the mindfulness intervention after first outcome assessment.

The proposed MBI is an adaptation from the Mindfulness Based Stress Reduction (MBSR) and Mindfulness based Cognitive Therapy (MBCT) programs to youth. This MBI consists of a total of twelve 90 minutes long sessions, the first 8 being the intervention per se and the last 4 a proposition to the transition to regular practice and a chance to better integrate mindfulness in daily life.

A theme regarding mindfulness is addressed in each session, through meditation practices and exercises. Between sessions, participants are invited to practice at home, using an application designed for this study (the MindApp), where participants can find the recorded practices. Investigators have access to participants' use of the meditation recordings and expect that these data will provide a more objective measure of the amount of home practice.

Comparateur placebo: Late Mindfulness Intervention

The Late MBI group partake on the mindfulness intervention after the second outcome assessment.

This groups is the control group for the Early MBI group.

After the second assessment, this group engage on the same intervention as the early group.

The proposed MBI is an adaptation from the Mindfulness Based Stress Reduction (MBSR) and Mindfulness based Cognitive Therapy (MBCT) programs to youth. This MBI consists of a total of twelve 90 minutes long sessions, the first 8 being the intervention per se and the last 4 a proposition to the transition to regular practice and a chance to better integrate mindfulness in daily life.

A theme regarding mindfulness is addressed in each session, through meditation practices and exercises. Between sessions, participants are invited to practice at home, using an application designed for this study (the MindApp), where participants can find the recorded practices. Investigators have access to participants' use of the meditation recordings and expect that these data will provide a more objective measure of the amount of home practice.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Brain activity in stress-related networks at functional MRI
Délai: At baseline, immediately after intervention, 18 months after intervention
Change of the fronto-limbic circuit recovery after a social laboratory stress using the Montreal Imaging Stress Task (MIST)
At baseline, immediately after intervention, 18 months after intervention
Brain gray matter at structural MRI
Délai: At baseline, immediately after intervention, 18 months after intervention
Change on gray matter volume in prefrontal areas
At baseline, immediately after intervention, 18 months after intervention
Brain connectivity at functional MRI
Délai: Before and after intervention
Change in structural connectivity measures between prefrontal and limbic areas after intervention
Before and after intervention
Brain cortical thickness at structural MRI
Délai: At baseline, immediately after intervention, 18 months after intervention
Cortical thickness in prefrontal areas
At baseline, immediately after intervention, 18 months after intervention

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Level of anxiety
Délai: At baseline, immediately after intervention, 18 months after intervention
Change of the level of anxiety measured by the State and Trait Anxiety Inventory. Minimum score 20, maximum score 60. Higher score means a worse outcome (higher anxiety).
At baseline, immediately after intervention, 18 months after intervention
Level of emotional awareness
Délai: At baseline, immediately after intervention, 18 months after intervention
Change on the baseline Emotion Awareness Questionnaire score after intervention. Minimum score 0, maximum score 40. Higher score means a better outcome.
At baseline, immediately after intervention, 18 months after intervention
Level of emotional regulation
Délai: At baseline, immediately after intervention, 18 months after intervention
Change on the baseline Emotion Regulation Questionnaire score after intervention. Minimum score 6, maximum score 30. Higher score means a better outcome.
At baseline, immediately after intervention, 18 months after intervention
Level of inflammation
Délai: At baseline, immediately after intervention, 18 months after intervention
Change on baseline innate immunity-related proteins after intervetion, measured in pg/ml.
At baseline, immediately after intervention, 18 months after intervention
Level redox system activity
Délai: At baseline, immediately after intervention, 18 months after intervention
Change on the baseline activity of plasma glutathion and metabolites after intervention, measured in mMol/L-
At baseline, immediately after intervention, 18 months after intervention
Hair cortisol level
Délai: At baseline, immediately after intervention, 18 months after intervention
Change on the baseline hair cortisol measure after intervention, measured in pg/mg.
At baseline, immediately after intervention, 18 months after intervention
Heart rate variability
Délai: At baseline, immediately after intervention, 18 months after intervention
Change on baseline herat rate variability after intervetion.
At baseline, immediately after intervention, 18 months after intervention
Level of redox system activity
Délai: At baseline, immediately after intervention, 18 months after intervention
Change on baseline activity of enzimes involved in glutathion metabolism after intervention, measured in U/gHb
At baseline, immediately after intervention, 18 months after intervention

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Camille Piguet, Physician, Geneva University

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

12 février 2019

Achèvement primaire (Anticipé)

30 novembre 2022

Achèvement de l'étude (Anticipé)

30 novembre 2022

Dates d'inscription aux études

Première soumission

16 mai 2019

Première soumission répondant aux critères de contrôle qualité

14 janvier 2021

Première publication (Réel)

15 janvier 2021

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

15 janvier 2021

Dernière mise à jour soumise répondant aux critères de contrôle qualité

14 janvier 2021

Dernière vérification

1 janvier 2021

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 2018-017731

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner